NOTE

DERIVATIVE FINANCIAL INSTRUMENTS

The Company records all derivative financial instruments at fair value in the financial statements. Derivatives are used as a risk management tool to hedge the exposure to changes in interest rates or other identified market risks.

When a derivative is intended to be a qualifying hedged instrument, the Company prepares written hedge documentation that designates the derivative as

) a hedge of fair value of a recognized asset or liability (fair value hedge) or

) a hedge of a forecasted transaction, such as, the variability of cash flows to be received or paid related to a recognized asset or liability (cash flow hedge). The written documentation includes identification of, among other items, the risk management objective, hedging instrument, hedged item, and methodologies for assessing and measuring hedge effectiveness and ineffectiveness, along with support for management’s assertion that the hedge will be highly effective.

June 2017,

the Company entered into a forward start interest rate swap agreement totaling

$50

million notional amount to hedge against interest rate risk on FHLB advances. As a cash flow hedge, the portion of the change in the fair value of the derivative that has been deemed highly effective is recognized in other comprehensive income until the related cash flows from the hedged item are recognized in earnings. At

December 31, 2019,

the Company reported a

$795,612

unrealized loss, net of a

$272,323

tax effect, in accumulated other comprehensive income related to this cash flow hedge.

March 2019,

the Company entered into an interest rate swap agreement totaling

$10.3

million notional amount to hedge against interest rate risk on variable rate subordinated debentures. As a cash flow hedge, the portion of the change in the fair value of the derivative that has been deemed highly effective is recognized in other comprehensive income until the related cash flows from the hedged item are recognized in earnings. At

December 31, 2019,

the Company reported a

$417,489

unrealized loss, net of a

$142,899

tax effect, in accumulated other comprehensive income related to this cash flow hedge.

For each instrument, the Company documents at inception and periodically over the life of the hedge, its analysis of actual and expected hedge effectiveness. To the extent that the hedge of future cash flows is deemed ineffective, changes in the fair value of the derivative are recognized in earnings as a component of other noninterest expense. For the year ended

December 31, 2019,

there was

ineffectiveness attributable to either cash flow hedge.

As of

December 31, 2019,

based on current fair values, the Company pledged cash collateral of

$1.9

million to its counterparty for the swaps. As of

December 31, 2018,

based on then current fair values, the counterparty had pledged cash collateral of

$1.5

million to the Company.

A summary of the Company’s derivative financial instruments at

December 31, 2019

and

2018

is shown in the following table:

December 31, 2019

Forward Start

Termination

Derivative

Notional

Rate

Balance Sheet

Estimated Fair Value at:

Inception Date

Date

Type

Amount

Paid

Hedged

Classfication

December 31, 2019

December 31, 2018

2/28/2018

2/28/2025

Interest rate swap - FHLB Advances

50,000,000

2.12

3 month LIBOR Floating

Other liabilites

(1,067,935

)

1,271,538

5/23/2019

2/23/2026

Interest rate swap - Subordinated Debentures

10,310,000

4.09

3 month LIBOR Floating +145 bps

Other liabilites

(560,388

)

The following table presents the net amounts included in the consolidated statements of income for derivatives designated as hedging instruments for the periods indicated:

Derivative	Income Statement	Years ended December 31,
Type	Classfication	2019			2018

Interest rate swap - FHLB Advances	Interest expense	$	(155,062	)	$	(60,388	)

Interest rate swap - Subordinated Debentures	Interest expense	$	24,065			-